Dr. Reggie Hui-Chao Lee received his PhD in Pharmacology from Tzu Chi University, Taiwan, in 2005. He completed his Post-Doctoral Fellow in Neurology from the University of Miami in 2013 to 2016. From 2016 to 2019, he completed a Post-Doctoral Fellow in Neurology from the LSU Health Shreveport. The overall research goal in Dr. Lee's laboratory is to study potential therapeutics against cerebral ischemia. The major research focus is to investigate the pathophysiological role of serum-/glucocorticoid-inducible kinase 1 (SGK1) in the context of cardiac arrest. His lab is currently investigating (1) the therapeutic potential of SGK1 inhibitors against cardiac arrest and (2) mechanisms underlying SGK1-mediated brain injury and neurological deficits after cardiac arrest. Dr. Lee's research interests include protein kinases, cerebral ischemia, neuroprotection, autonomic nervous system, and cerebral blood flow autoregulation.
Dr. Reggie Hui-Chao Lee received his PhD in Pharmacology from Tzu Chi University, Taiwan, in 2005. He completed his Post-Doctoral Fellow in Neurology from the University of Miami in 2013 to 2016. From 2016 to 2019, he completed a Post-Doctoral Fellow in Neurology from the LSU Health Shreveport. The overall research goal in Dr. Lee's laboratory is to study potential therapeutics against cerebral ischemia. The major research focus is to investigate the pathophysiological role of serum-/glucocorticoid-inducible kinase 1 (SGK1) in the context of cardiac arrest. His lab is currently investigating (1) the therapeutic potential of SGK1 inhibitors against cardiac arrest and (2) mechanisms underlying SGK1-mediated brain injury and neurological deficits after cardiac arrest. Dr. Lee's research interests include protein kinases, cerebral ischemia, neuroprotection, autonomic nervous system, and cerebral blood flow autoregulation.